KinCon biolabs Patents

Patent portfolio assigned to KinCon biolabs (verified via public assignee records). Austria (Innsbruck) University of Innsbruck spin-off; bioluminescence KinCon kinase-conformation biosensor platform (described as 'patented'). Patent family confirmed (EP3519830A1 'Full length kinase activity-conformation reporter'; US12130292B2 in USPTO gazette). Customers referenced only anonymously ('a NASDAQ-listed biotech', 'a leading pharma company') so none nameable. No competitors named.